bleve bvibrant
Dosage form: lotion
Ingredients: OCTINOXATE 2mL in 100mL, AVOBENZONE 0.5mL in 100mL
Labeler: TOPCO ASSOCIATES LLC
NDC Code: 36800-353
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
OCTYL METHOXYCINNAMATE 2%
AVOBENZONE 0.5%
SKIN PROTECTANT
SKIN PROTECTANT
HELPS PREVENT SUNBURN.
FOR EXTERNAL USE ONLY.
SPENDING TIME IN THE SUN INCREASES YOUR RISK OF SKIN CANCER AND EARLY SKIN AGING. THIS PRODUCT HAS BEEN SHOWN ONLY TO HELP PREVENT SUNBURN, NOT SKIN CANCER OR EARLY SKIN AGING.
AVOID CONTACT WITH EYES. IF CONTACT OCCURS, RINSE EYES THOROUGHLY WITH WATER.
IRRITATION OR REDNESS DEVELOPS AND LASTS.
IN CASE OF ACCIDENTAL INGESTION, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.
APPLY LIBERALLY 15 MINUTES BEFORE EXPOSURE TO SUN. USE A WATER RESISTANT SUNSCREEN IF SWIMMING OR SWEATING. REAPPLY AT LEAST EVERY TWO HOURS. FOR CHILDREN UNDER 6 MONTHS, ASK A DOCTOR.
WATER (AQUA), CARTHAMUS TINCTORIUS (SAFFLOWER) OLEOSOMES, GLYCINE SOJA (SOYBEAN) OIL, C12-15 ALKYL BENZOATE, POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE, GLYCERYL STEARATE, CETYL ALCOHOL, STEARYL ALCOHOL, DIMETHICONE,VITIS VINIFERA (GRAPE) FRUIT CELL EXTRACT, ISOMALT, LECITHIN, SODIUM BENZOATE, PALMITOYL TRIPEPTIDE-38, GLYCERIN, HYDROXYPROPYL CYCLODEXTRIN, INULIN, AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER, FRAGRANCE (PARFUM), PHENOXYETHANOL, TROPOLONE.
| BLEVE
BVIBRANT
octyl methoxycinnamate lotion |
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
| Labeler - TOPCO ASSOCIATES LLC (006935977) |
| Registrant - APOLLO HEALTH AND BEAUTY CARE (201901209) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| APOLLO HEALTH AND BEAUTY CARE | 201901209 | manufacture | |
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
